NCT00911586View on ClinicalTrials.gov

Pharmacokinetic Study to Determine Time to Steady-state

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

January 31, 2010

Conditions
Male HypogonadismPrimary HypogonadismSecondary Hypogonadism
Interventions
DRUG

Testosterone undecanoate

Trial Locations (1)

35235

Alabama Clinical Therapeutics, Birmingham

Sponsors
All Listed Sponsors
lead

Clarus Therapeutics, Inc.

INDUSTRY

NCT00911586 - Pharmacokinetic Study to Determine Time to Steady-state | Biotech Hunter | Biotech Hunter